Tuesday, August 11, 2020 1:32:23 PM
https://www.fuw.ch/article/relief-therapeutics-ist-ein-virtuelles-unternehmen/
The hope for effective means has already driven the shares of some small pharmaceutical companies to unimagined heights during the corona crisis. But none shows a more phenomenal price increase of more than 40,000% than Relief Therapeutics. On the one hand, this is due to the fact that it was valued at just CHF 2 million on the stock exchange at the beginning of the year, and on the other hand, it is due to the prospect of a drug against Covid-19.
Since the company announced the first results of its active ingredient Aviptadil (RLF-100) last week, the shares have taken off. In an interview with “Finanz und Wirtschaft”, Chairman of the Board of Directors Raghuram Selvaraju is confident: “We hope that Aviptadil delivers better results than Remdesivir.” Gilead's drug is the first and so far only in a scientific study to have a positive effect on disease progression and has received emergency approval.
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM